Excellent piece of news from OZSC and certainly filled with plenty of reasons to be optimistic here.
The best part is the listing of all that has been laid out for this year.
From the announcement:
Key planned events 2019
As we continue to evaluate our IP portfolio, we plan to broaden the scope of our claims as it relates to balloon technology for fusion and motion preservation in the disc.
Initiate IR program to build liquidity in our stock – we will kick off our investment relations program to build investor and market awareness of our company.
Upcoming trade shows/presentations – we plan to present our company at select and targeted venues, starting with the MicroCap conference April 1 and 2 in New York City. We believe it is important to raise our visibility with brokers, investment bankers and market makers. Other events are in the planning stages and will be announced as they come up.
Begin core spine fusion sales, including the new expandable ALIF and scale this program using our existing surgeon/distributor relationships. This includes evaluating our implant offering to insure it meets surgeon needs and upgrading the instrumentation as needed. Depending on the complexity of the changes we will file for additional FDA 510K approvals as needed.
Determine focus and strategy for spine scope program.
Build out our Clinical Advisory Board with nationally recognized spine surgeons.
Independent board of directors, in the future, we will build our board of directors by adding independent members with critical experience in the Nasdaq uplist process, deep experience in public markets, and senior level experience in our industry. Uplist to Nasdaq is our ultimate goal to enable us to access the institutional investor sector and further enhance the liquidity of our stock.
